Cargando…

Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder

Neuromyelitis optica spectrum disorder (NMOSD) is an immune-related demyelinating defect. Long non-coding RNAs (lncRNAs) might influence the pathobiology and progression of NMOSD. The current study assessed expression level of NEAT1, PANDAR, MEG3 and TUG1 lncRNAs in the peripheral blood of NMOSD pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Taheri, Mohammad, Sadeghi, Ahmad, Gharebaghi, Alireza, Ghiasian, Masoud, Eslami, Solat, Khalilian, Sheyda, Sayad, Arezou, Ghafouri-Fard, Soudeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618193/
https://www.ncbi.nlm.nih.gov/pubmed/37907501
http://dx.doi.org/10.1038/s41598-023-45457-w
_version_ 1785129721183338496
author Taheri, Mohammad
Sadeghi, Ahmad
Gharebaghi, Alireza
Ghiasian, Masoud
Eslami, Solat
Khalilian, Sheyda
Sayad, Arezou
Ghafouri-Fard, Soudeh
author_facet Taheri, Mohammad
Sadeghi, Ahmad
Gharebaghi, Alireza
Ghiasian, Masoud
Eslami, Solat
Khalilian, Sheyda
Sayad, Arezou
Ghafouri-Fard, Soudeh
author_sort Taheri, Mohammad
collection PubMed
description Neuromyelitis optica spectrum disorder (NMOSD) is an immune-related demyelinating defect. Long non-coding RNAs (lncRNAs) might influence the pathobiology and progression of NMOSD. The current study assessed expression level of NEAT1, PANDAR, MEG3 and TUG1 lncRNAs in the peripheral blood of NMOSD patients compared with healthy individuals. All mentioned lncRNAs were shown to be over-expressed in total NMOSD cases, male NMOSD cases and female NMOSD cases compared with the matching control subgroups. MEG3 had the most robust over-expression in patients subgroups compared with normal subjects. There was no noteworthy difference in the expression of any of lncRNAs between female and male patients. MEG3 had an ideal performance in the differentiation of NMOSD cases from healthy persons (Sensitivity and specificity values = 100%). Other lncRNAs could also efficiently separate NMOSD cases from control subjects (AUC values = 0.97, 0.89 and 0.88 for PANDAR, NEAT1 and TUG1, respectively). Cumulatively, NEAT1, PANDAR, MEG3 and TUG1 lncRNAs can be considered as appropriate disease markers for NMOSD.
format Online
Article
Text
id pubmed-10618193
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106181932023-11-02 Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder Taheri, Mohammad Sadeghi, Ahmad Gharebaghi, Alireza Ghiasian, Masoud Eslami, Solat Khalilian, Sheyda Sayad, Arezou Ghafouri-Fard, Soudeh Sci Rep Article Neuromyelitis optica spectrum disorder (NMOSD) is an immune-related demyelinating defect. Long non-coding RNAs (lncRNAs) might influence the pathobiology and progression of NMOSD. The current study assessed expression level of NEAT1, PANDAR, MEG3 and TUG1 lncRNAs in the peripheral blood of NMOSD patients compared with healthy individuals. All mentioned lncRNAs were shown to be over-expressed in total NMOSD cases, male NMOSD cases and female NMOSD cases compared with the matching control subgroups. MEG3 had the most robust over-expression in patients subgroups compared with normal subjects. There was no noteworthy difference in the expression of any of lncRNAs between female and male patients. MEG3 had an ideal performance in the differentiation of NMOSD cases from healthy persons (Sensitivity and specificity values = 100%). Other lncRNAs could also efficiently separate NMOSD cases from control subjects (AUC values = 0.97, 0.89 and 0.88 for PANDAR, NEAT1 and TUG1, respectively). Cumulatively, NEAT1, PANDAR, MEG3 and TUG1 lncRNAs can be considered as appropriate disease markers for NMOSD. Nature Publishing Group UK 2023-10-31 /pmc/articles/PMC10618193/ /pubmed/37907501 http://dx.doi.org/10.1038/s41598-023-45457-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Taheri, Mohammad
Sadeghi, Ahmad
Gharebaghi, Alireza
Ghiasian, Masoud
Eslami, Solat
Khalilian, Sheyda
Sayad, Arezou
Ghafouri-Fard, Soudeh
Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder
title Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder
title_full Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder
title_fullStr Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder
title_full_unstemmed Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder
title_short Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder
title_sort significant up-regulation of lncrnas in neuromyelitis optica spectrum disorder
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618193/
https://www.ncbi.nlm.nih.gov/pubmed/37907501
http://dx.doi.org/10.1038/s41598-023-45457-w
work_keys_str_mv AT taherimohammad significantupregulationoflncrnasinneuromyelitisopticaspectrumdisorder
AT sadeghiahmad significantupregulationoflncrnasinneuromyelitisopticaspectrumdisorder
AT gharebaghialireza significantupregulationoflncrnasinneuromyelitisopticaspectrumdisorder
AT ghiasianmasoud significantupregulationoflncrnasinneuromyelitisopticaspectrumdisorder
AT eslamisolat significantupregulationoflncrnasinneuromyelitisopticaspectrumdisorder
AT khaliliansheyda significantupregulationoflncrnasinneuromyelitisopticaspectrumdisorder
AT sayadarezou significantupregulationoflncrnasinneuromyelitisopticaspectrumdisorder
AT ghafourifardsoudeh significantupregulationoflncrnasinneuromyelitisopticaspectrumdisorder